Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classement en actions #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Prix de l'action
$0.404
Capitalisation boursière
$14.28M
Changement (1 jour)
-10.42%
Changement (1 an)
-67.68%
Pays
IL
Échange NeuroSense Therapeutics Ltd. (NRSN)

Catégorie

Historique du prix de l'action pour NeuroSense Therapeutics Ltd. (NRSN)
Prix de clôture le plus élevé : $0.47 le 2026-08-01

Prix de clôture le plus bas : $3.04 le 2021-12-01
Historique du prix de l'action de NeuroSense Therapeutics Ltd. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$528.88 35.65%
US
$1.00K 51.38%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE